Exhibit 31.3
CERTIFICATION OF PERIODIC REPORT
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Oren Gilad, certify that:
1. | I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Aprea Therapeutics, Inc. for the year ended December 31, 2022; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report |
Date: April 28, 2023 | | |
| | |
| | /s/ Oren Gilad |
| | Oren Gilad., Ph.D. |
| | President and Chief Executive Officer |
| | (Principal Executive Officer) |